switching from semaglutide to tirzepatide Tirzepatide: What to Expect — Affinity Whole Health Switching from Semaglutide to Tirzepatide

Identifying Contraindications Some lab results might wave a red flag, making GLP-1 treatment not the best option or requiring extra care

Description CJC 1295 No Dac (5mg) + Ipamorelin (10mg) Blend Calculation: One pen contains 300 units of 50mcg (16.7mcg CJC No DAC and 33.3 mcg Ipamorelin) Examples of calculated units per pen of CJC 1295 No DAC (5 mg) + Ipamorelin (10 mg) BLEND corresponding to micrograms: 1 unit = 16.7 mcg CJC No DAC and 33.3 mcg Ipamorelin

Improves Skin Complexion Helps lighten skin, reduce dullness, and enhance overall skin health

Phase Low-moderate Daily dose 20-50 mcg/day Site Trained muscle, post-workout Notes Often used in research interest in localized hypertrophy signaling

GLP1s help reset hunger and portion control, but long-term success depends on building healthy habits

However, these agents increase risk of intra-operative pulmonary aspiration according to a case report secondary to delayed emptying and presence of gastric residues despite fasting (108, 108) To prevent these events, the recent recommendations from the American Society of Anesthesiology guidelines suggest discontinuing GLP-1 receptor agonists 1 day prior in patients on daily dosing and 1 week prior in patients on weekly injection dosing (108)